Clinical Trials

    Xeltis Hemodialysis Access Graft (aXess) US Study

    Investigator: Eric Peden

    Study Coordinator: Solange Basagoitia

    Status: Enrolling

    ClinicalTrials.gov Number: NCT05473299

    Phone: 713.441.0176

    Protocol Number: PRO00039198

    Description


    A multi-center, prospective, single-arm, non-randomized, staged, pivotal clinical study to evaluate the safety and performance of the aXess graft in subjects aged 18 and above, diagnosed with end-stage kidney disease, and possessing an estimated glomerular filtration rate (eGFR) less than 20 ml/min, who intend to undergo hemodialysis but are considered unsuitable candidates for fistula creation by the investigating surgeon.